Results 231 to 240 of about 6,119,378 (259)
Some of the next articles are maybe not open access.
Autologous Hematopoietic Stem Cell Transplantation for Childhood Autoimmune Disease
Pediatric Clinics of North America, 2010Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) can be used in the management of patients with autoimmune disorders. Experience gained in adults has helped to better define the conditioning regimens required and appropriate selection of patients who are most likely to benefit from autologous HSCT.
Francesca, Milanetti +3 more
openaire +2 more sources
Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Neurologic ClinicsIn aggregate, the available data suggest autologous hematopoietic stem cell transplantation (AHSCT) has potent, durable efficacy to treat relapsing multiple sclerosis (MS). Safety issues and financial costs are significant but largely associated with the procedure itself.
Lindsay A, Ross +2 more
openaire +2 more sources
Autologous Hematopoietic Stem Cell Transplantation for Type 1 Diabetes
Annals of the New York Academy of Sciences, 2008In this review, we present (1) the scientific basis for the use of high‐dose immunosuppression followed by autologous peripheral blood hematopoietic stem cell transplantation for newly diagnosed type 1 diabetes (T1D); (2) an update of the clinical and laboratory outcome of 20 patients transplanted at the University Hospital of the Ribeirão Preto ...
Júlio C, Voltarelli +13 more
openaire +2 more sources
Autologous Hematopoietic Stem Cell Transplantation in Non-Hodgkin’s Lymphomas
Acta Haematologica, 2005Early studies on high-dose therapy followed by autologous bone marrow transplantation demonstrated the safety and efficacy of this approach in non-Hodgkin’s lymphoma (NHL). As the procedure became easier and safer with the introduction of peripheral blood progenitor cells instead of marrow, the popularity of this procedure declined. In the last decade,
openaire +3 more sources
The role of autologous hematopoietic stem cell transplantation in hematologic malignancy
Current Opinion in Oncology, 1994Supraintensive cytoreductive therapy with hematopoietic stem cell rescue (HSCR) is able to provide curative therapy in a number of hematologic malignancies. Allogeneic HSCR is limited to less than 50% of patients because of the absence of related or unrelated compatible donors.
openaire +2 more sources
The Principles and Overview of Autologous Hematopoietic Stem Cell Transplantation
2008William, Vaughan +3 more
openaire +2 more sources

